RE:RE:RE:Listened to the Stifel-GMP call again ...Knight Therapeutics Revenue
Last 4 quarters - $240,400,000 (just for comparison)
2020 - $199,519,000
2019 - $47,461,000
2018 - $12,500,000
2017 - $8,634,000
2016 - $5,940,000
2015 - $1,037,000
2014 - $365,000
---------------
If Q4 is as good as 2020 Q4 ($55M) we'd hit $240K in sales for 2021.
That would be more than 20% increase y-o-y.
Just think about that one!